Humana Inc. stock performance trend indicates that the stock price has rallied 6.51% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 23.75% . Looking at the past 52 week period, the stock price is up at 18.58% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Humana Inc. has a positive value of 12.1 compared to overall market.Humana Inc. is having a Relative Strength Index of 65 which indicates the stock is not yet over sold or over bought based on the technical indicators.
Humana Inc. (NYSE:HUM) has climbed 0.45% in the past week and advanced 6.99% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 0.21% and the outperformance has advanced to 5.77% for the last 4 weeks period.
For the current week, the company shares have a recommendation consensus of Buy. Humana Inc. (NYSE:HUM) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.35 points or 0.16% at $218.9 with 1,515,116 shares getting traded. Post opening the session at $219.37, the shares hit an intraday low of $217.635 and an intraday high of $220 and the price was in this range throughout the day. The company has a market cap of $31,584 million and the number of outstanding shares has been calculated to be 144,284,500 shares. The 52-week high of Humana Inc. (NYSE:HUM) is $220.49 and the 52-week low is $150.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Humana Inc was Resumed by BofA/Merrill to Buy on Jan 27, 2017. Humana Inc was Downgraded by Stifel on Jan 24, 2017 to Hold, Lowers Price Target to $ 210 from a previous price target of $214 .Humana Inc was Initiated by Piper Jaffray to Overweight on Jan 4, 2017.
Company has reported several Insider transactions to the SEC, on Mar 7, 2017, James E Murray (EVP & COO) sold 31,151 shares at 213.62 per share price.On Mar 6, 2017, Webster Roy Dunbar (director) sold 3,000 shares at 213.12 per share price.On Mar 6, 2017, Cynthia H Zipperle (Vice President, CAO,Controller) sold 1,885 shares at 213.37 per share price.
Humana Inc Last issued its quarterly earnings results on Feb 8, 2017. The company reported $2.09 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $2.08. The company had revenue of $13461.00 million for the quarter, compared to analysts expectations of $13540.09 million. The companys revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 EPS.
Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. The companys products are marketed primarily through health maintenance organizations and preferred provider organizations that encourage or require the use of contracted providers. The company also offers various specialty products to employers, including dental, group life and workers compensation, and administrative services to those who self-insure their employee health plans.